Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M441Revenue (TTM) $M91.4Net Margin (%)-124.6Altman Z-Score-10.7
Enterprise Value $M627EPS (TTM) $-0.8Operating Margin %-103.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-127.8Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-15.3Quick Ratio1.9Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %-24.9Current Ratio2.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-61.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M185ROIC % (ttm)-1,980.6Gross Margin Increase y-yY

Gurus Latest Trades with AMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRNGeorge Soros 2012-09-30 Sold Out -0.06%$11.17 - $15.49
($13.55)
$ 2.38-82%Sold Out0
AMRNGeorge Soros 2012-06-30 Buy 0.06%$9.47 - $14.74
($11.35)
$ 2.38-79%New holding300,000
AMRNGeorge Soros 2011-09-30 Sold Out -0.058%$8.95 - $14.82
($12)
$ 2.38-80%Sold Out0
AMRNGeorge Soros 2011-06-30 Reduce-0.04%$7.39 - $19.5
($15)
$ 2.38-84%Reduce -56.15%285,000
AMRNGeorge Soros 2011-03-31 Reduce-0.04%$7.03 - $9.33
($8.1)
$ 2.38-71%Reduce -42.66%650,000
AMRNGeorge Soros 2010-12-31 Buy 0.12%$2.49 - $8.49
($4.48)
$ 2.38-47%New holding1,133,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
THERO JOHN FPresident and CEO 2016-02-01Buy25,000$1.3772.99view
THERO JOHN FPresident and CEO 2015-08-11Buy20,000$2.350.85view
THERO JOHN FPresident, Chief Exec. Officer 2014-11-12Buy50,000$0.83185.54view
Farrell Michael JamesController 2014-11-11Buy5,500$0.84182.14view
Southpoint Capital Advisors LP10% Owner 2006-04-20Sell0$0182.14view

Press Releases about AMRN :

Quarterly/Annual Reports about AMRN:

News about AMRN:

Articles On GuruFocus.com
Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 23 2014 
Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN Jan 07 2013 
Steven Cohen Adds Amarin Corp. Awaiting Drug Approval, Buys Hyatt Hotels Mar 28 2012 
Soros Funds’ Great Britain Buys and Sells Apr 13 2011 

More From Other Websites
ETF’s with exposure to Amarin Corp. Plc : July 20, 2016 Jul 20 2016
Coverage Initiated on Select Drug Manufacturer Stocks Jul 15 2016
AMARIN CORP PLC\UK Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 14 2016
Amarin to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference Jul 06 2016
Amarin to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference Jul 06 2016
ETF’s with exposure to Amarin Corp. Plc : July 1, 2016 Jul 01 2016
AMARIN CORP PLC\UK Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... Jun 30 2016
Amarin Appoints Michael W. Kalb Chief Financial Officer Jun 30 2016
Amarin Appoints Michael W. Kalb Chief Financial Officer Jun 30 2016
Featured Research Report on Drug Manufacturers Stocks Jun 14 2016
Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid... Jun 11 2016
Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid... Jun 11 2016
AMARIN CORP PLC\UK Files SEC form 8-K, Regulation FD Disclosure Jun 08 2016
Vascepa(R) (Icosapent Ethyl) Data to Be Presented at American Diabetes Association's 76th Scientific... Jun 06 2016
Vascepa(R) (Icosapent Ethyl) Data to Be Presented at American Diabetes Association's 76th Scientific... Jun 06 2016
Amarin (AMRN) Looks Good: Stock Adds 6.7% in Session Jun 03 2016
Amarin to Present at the Jefferies 2016 Global Healthcare Conference Jun 01 2016
Amarin to Present at the Jefferies 2016 Global Healthcare Conference Jun 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)